These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28886889)

  • 1. Anti-influenza activity of diazaadamantanes combined with monoterpene moieties.
    Suslov E; Zarubaev VV; Slita AV; Ponomarev K; Korchagina D; Ayine-Tora DM; Reynisson J; Volcho K; Salakhutdinov N
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4531-4535. PubMed ID: 28886889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-influenza activity of monoterpene-containing substituted coumarins.
    Khomenko TM; Zarubaev VV; Orshanskaya IR; Kadyrova RA; Sannikova VA; Korchagina DV; Volcho KP; Salakhutdinov NF
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2920-2925. PubMed ID: 28501512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
    Zarubaev VV; Golod EL; Anfimov PM; Shtro AA; Saraev VV; Gavrilov AS; Logvinov AV; Kiselev OI
    Bioorg Med Chem; 2010 Jan; 18(2):839-48. PubMed ID: 20006516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective synthesis of novel adamantane derivatives with high potency against rimantadine-resistant influenza A virus strains.
    Kuznetsov NY; Tikhov RM; Godovikov IA; Medvedev MG; Lyssenko KA; Burtseva EI; Kirillova ES; Bubnov YN
    Org Biomol Chem; 2017 Apr; 15(15):3152-3157. PubMed ID: 28338150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-influenza activity of monoterpene-derived substituted hexahydro-2H-chromenes.
    Patrusheva OS; Zarubaev VV; Shtro AA; Orshanskaya YR; Boldyrev SA; Ilyina IV; Kurbakova SY; Korchagina DV; Volcho KP; Salakhutdinov NF
    Bioorg Med Chem; 2016 Nov; 24(21):5158-5161. PubMed ID: 27591012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
    Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP
    Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
    Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
    Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
    Göktaş F; Vanderlinden E; Naesens L; Cesur N; Cesur Z
    Bioorg Med Chem; 2012 Dec; 20(24):7155-9. PubMed ID: 23117173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
    Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
    Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
    Du QS; Huang RB; Wang SQ; Chou KC
    PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
    Wang JF; Wei DQ; Chou KC
    Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
    Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
    Zoidis G; Kolocouris N; Naesens L; De Clercq E
    Bioorg Med Chem; 2009 Feb; 17(4):1534-41. PubMed ID: 19195900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
    Bright RA; Shay DK; Shu B; Cox NJ; Klimov AI
    JAMA; 2006 Feb; 295(8):891-4. PubMed ID: 16456087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
    Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
    Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adamantane resistance among seasonal influenza A viruses between January to October in Guangzhou, 2009].
    Yang ZF; Guan WD; Xu GR; Li MY; Mo ZY; Luo Y; Dong WN; Wang YT; Qin S; Zhan YQ; Zhang X; Huang QD; Zhao SS; Zhou R; Chen RC; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Feb; 34(2):95-9. PubMed ID: 21426725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
    Rey-Carrizo M; Torres E; Ma C; Barniol-Xicota M; Wang J; Wu Y; Naesens L; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2013 Nov; 56(22):9265-74. PubMed ID: 24237039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of bioactive adamantane spiro heterocycles.
    Kolocouris N; Zoidis G; Foscolos GB; Fytas G; Prathalingham SR; Kelly JM; Naesens L; De Clercq E
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4358-62. PubMed ID: 17588747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.
    Kolocouris A; Tzitzoglaki C; Johnson FB; Zell R; Wright AK; Cross TA; Tietjen I; Fedida D; Busath DD
    J Med Chem; 2014 Jun; 57(11):4629-39. PubMed ID: 24793875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007).
    Pabbaraju K; Ho KC; Wong S; Shokoples S; Pang XL; Fonseca K; Fox JD
    Antiviral Res; 2008 Aug; 79(2):81-6. PubMed ID: 18258311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.